Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immune monitoring of T-cell responses during belatacept therapy after kidney transplantation
2012-003169-16Phase 4Active
- Sponsor
- Erasmus MC
- Start
- Aug 2012
- Modality
- Fc-Fusion Proteins → Carrier/Scaffold Proteins → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of belatacept in kidney allograft rejection, sponsored by Erasmus MC. Started Aug 2012; status: active.
02
Drugs
belatacept
03
Conditions
kidney allograft rejection
Beyond the preview
Go deeper on 2012-003169-16.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-003169-16.